搜索临床试验以：灭活二价（O1 和 O139）全细胞口服霍乱疫苗
总计20个结果
-
International Vaccine InstituteChristian Medical College, Vellore, India; Shantha Biotechnics Limited完全的
-
International Vaccine InstituteShantha Biotechnics Limited; Armauer Hansen Research Institute, Ethiopia; Ministry of Health,...完全的
-
International Vaccine InstituteNational Institute of Cholera and Enteric Diseases, India; Shantha Biotechnics Limited完全的
-
Jiangsu Province Centers for Disease Control and...完全的口服 O1 / O139 霍乱疫苗（肠溶胶囊）的安全性
-
Sachin DesaiIndian Council of Medical Research; National Institute of Cholera and Enteric Diseases, India完全的
-
International Vaccine InstituteNational Institute of Cholera and Enteric Diseases, India; Shantha Biotechnics Limited完全的
-
Johns Hopkins Bloomberg School of Public HealthBill and Melinda Gates Foundation; Meilleur Accès aux Soins de Santé (M.A. Santé)完全的
-
International Vaccine InstituteIndian Council of Medical Research; National Institute of Cholera and Enteric Diseases, India; Shantha Biotechnics Limited完全的
-
International Vaccine InstituteIndian Council of Medical Research; Institute of Child Health; National Institute of Cholera and... 和其他合作者未知
-
International Centre for Diarrhoeal Disease Research...Göteborg University; Kyoto University完全的
-
International Vaccine InstituteGöteborg University; National Institute of Hygiene and Epidemiology, Vietnam完全的
-
International Vaccine InstituteIndian Council of Medical Research; National Institute of Cholera and Enteric Diseases, India; Shantha Biotechnics Limited完全的
-
PATHBeijing Bio-Institute Biological Products Co., Ltd., formerly Beijing TiantanBio完全的
-
Universiteit AntwerpenChulalongkorn University; Thrasher Research Fund; Institut Pasteur de Lille完全的
-
Ology Bioservices完全的
-
Sanofi Pasteur, a Sanofi Company完全的百日咳免疫 | 白喉免疫 | 破伤风免疫 | 肺炎球菌免疫 | 乙型肝炎免疫 | 脊髓灰质炎免疫 | B型流感嗜血杆菌免疫 | 轮状病毒免疫泰国
-
GlaxoSmithKline完全的